TB Alliance's Pretomanid Seems OK Heading To Advisory Cmte. As US FDA Showcases Regulatory Flexibility

 
• By Michael Cipriano
Tuberculosis
TB Alliance's Pretomanid Heads To A US FDA Advisory Committee In Good Shape

More from US FDA Performance Tracker

More from Regulatory Trackers